China Universal Asset Management Co., Ltd. Crispr Therapeutics Ag Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 18,098 shares of CRSP stock, worth $899,832. This represents 0.07% of its overall portfolio holdings.
Number of Shares
18,098
Previous 16,381
10.48%
Holding current value
$899,832
Previous $769,000
7.41%
% of portfolio
0.07%
Previous 0.09%
Shares
16 transactions
Others Institutions Holding CRSP
# of Institutions
494Shares Held
64.3MCall Options Held
1.68MPut Options Held
1.95M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$446 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$435 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$190 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$138 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.75MShares$137 Million1.21% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.88B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....